Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02068040 · ClinicalTrials.gov registry record · NA
Effects of Epicatechin on Functional Capacity, Skeletal Muscle Structure and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction (HFPEF)
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02068040 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 7 participants.
The verdict
NCT02068040, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The major goal of this proposal is to characterize the ability of epicatechin which a component of dark chocolate to improve the 1. structural and functional features of skeletal muscle (SkM) 2. exercise capacity (as assessed by VO2 max) 3. parameters of diastolic heart function (as assessed by echocardiography) We propose that a 3 month treatment with epicatechin (through CocoaVia® capsules) will lead to a significant improvement in exercise capacity and diastolic function.
Interventions
- DIETARY_SUPPLEMENT CocoaVia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02068040
The ClinicalTrials.gov registry entry for NCT02068040 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CocoaVia is the first listed.
NCT02068040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02068040 about?
NCT02068040 is a clinical study titled "Effects of Epicatechin on Functional Capacity, Skeletal Muscle Structure and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction (HFPEF)". The major goal of this proposal is to characterize the ability of epicatechin which a component of dark chocolate to improve the 1. structural and functional features of skeletal muscle (SkM) 2. exercise capacity (as assessed by VO2 max) 3. parameters of diastolic heart function (as assessed by ech...
What is the current status of trial NCT02068040?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2014-01. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02068040?
The interventions under investigation include: CocoaVia (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02068040?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.